Recursion Pharmaceuticals
RXRX
RXRX
158 hedge funds and large institutions have $953M invested in Recursion Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 43 reducing their positions, and 26 closing their positions.
Holders
158
Holders Change
–
Holders Change %
0%
% of All Funds
2.49%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
26
Increased
58
Reduced
43
Closed
26
Calls
$1.04M
Puts
$765K
Net Calls
+$272K
Net Calls Change
+$22K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CPWM
176
Cypress Point Wealth Management
Dallas,
Texas
| – | -$94.8K | -14,219 | Closed |
|
|
CC
177
Centiva Capital
New York
| – | -$90.8K | -13,618 | Closed |
|
|
PMEF
178
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$89.2K | -13,376 | Closed |
|
|
ACM
179
Aquatic Capital Management
Chicago,
Illinois
| – | -$62K | -9,300 | Closed |
|
|
IUHSA
180
Itau Unibanco Holding S.A.
Sao Paulo,
Brazil
| – | -$14.3K | -2,138 | Closed |
|
|
SC
181
Slow Capital
Greenbrae,
California
| – | -$9.34K | -1,400 | Closed |
|
|
ASN
182
Advisory Services Network
Atlanta,
Georgia
| – | -$2K | -300 | Closed |
|
183
Man Group
London,
United Kingdom
| – | -$174K | – | – |
|